N-PORT filing recap · December 2025
What did Sound Shore Fund buy in December 2025?
Reported stock-position changes between this filing and the previous one. These are Sound Shore Fund's own holdings, not the firm's.
Stock value
$941.27M
Positions
37
Estimated turnover
38.4%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Sound Shore Fund opened new positions in Salesforce, Qxo, and BP during December, while exiting Hologic, International Paper, PayPal, and Perrigo. The fund sharply increased its stake in Regeneron Pharmaceuticals and substantially added to Public Service Enterprise Group and Kyndryl Holdings. It trimmed Teva Pharmaceutical, Nestle, Citigroup, Capital One, Bank of America, General Motors, Coterra Energy, and several others, with a substantial reduction in Warner Bros. Discovery.